Mattias Berglund
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gunilla Enblad
- E-mail:
- mattias.berglund@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
SE-75185 Uppsala
Sweden - Postal address:
- Rudbecklaboratoriet
SE-75185 Uppsala
Sweden
Publications
Recent publications
-
Part of Leukemia and Lymphoma, p. 1327-1334, 2026
- DOI for Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
- Download full text (pdf) of Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
-
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Cell Reports Medicine, 2025
- DOI for Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
- Download full text (pdf) of Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
-
Part of Leukemia, p. 438-441, 2024
- DOI for Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
- Download full text (pdf) of Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
-
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of iScience, 2023
- DOI for ADAR1-mediated RNA editing promotes B cell lymphomagenesis
- Download full text (pdf) of ADAR1-mediated RNA editing promotes B cell lymphomagenesis
-
Part of Genes, Chromosomes and Cancer, p. 27-36, 2022
- DOI for Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
- Download full text (pdf) of Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
All publications
Articles in journal
-
Part of Leukemia and Lymphoma, p. 1327-1334, 2026
- DOI for Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
- Download full text (pdf) of Neoehrlichia mikurensis infection associated with lymphoma or mimicking lymphoma in two cohorts of Swedish patients
-
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Cell Reports Medicine, 2025
- DOI for Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
- Download full text (pdf) of Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
-
Part of Leukemia, p. 438-441, 2024
- DOI for Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
- Download full text (pdf) of Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
-
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of iScience, 2023
- DOI for ADAR1-mediated RNA editing promotes B cell lymphomagenesis
- Download full text (pdf) of ADAR1-mediated RNA editing promotes B cell lymphomagenesis
-
Part of Genes, Chromosomes and Cancer, p. 27-36, 2022
- DOI for Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
- Download full text (pdf) of Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
-
The dual role of CD70 in B‐cell lymphomagenesis
Part of Clinical and Translational Medicine, 2022
- DOI for The dual role of CD70 in B‐cell lymphomagenesis
- Download full text (pdf) of The dual role of CD70 in B‐cell lymphomagenesis
-
Part of Acta Oncologica, p. 531-538, 2021
- DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
- Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
-
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Part of Haematologica, p. 2502-2506, 2021
- DOI for Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
- Download full text (pdf) of Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
-
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
Part of eJHaem, p. 199-207, 2020
- DOI for Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
- Download full text (pdf) of Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
-
Part of Acta Oncologica, p. 106-109, 2017
-
Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma
Part of European Journal of Haematology, p. 52-56, 2017
-
Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
Part of Blood Cancer Journal, 2016
- DOI for Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
- Download full text (pdf) of Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
-
Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
Part of PLOS ONE, 2016
- DOI for Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
- Download full text (pdf) of Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
-
Part of Acta Oncologica, p. 1126-1131, 2016
-
Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells
Part of Medical Oncology, 2015
-
Part of Acta Oncologica, p. 924-932, 2015
-
FOXR1 Activation in B-Cell Lymphoma
Part of Blood, 2015
-
Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
Part of Genes, Chromosomes and Cancer, p. 750-768, 2014
- DOI for Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
- Download full text (pdf) of Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
-
Part of European Journal of Haematology, p. 500-508, 2014
-
U-2932: two clones in one cell line, a tool for the study of clonal evolution
Part of Leukemia, p. 1155-1164, 2013
-
Part of International Journal of Hematology, p. 465-471, 2013
-
DNA repair genes are selectively mutated in diffuse large B cell lymphomas
Part of Journal of Experimental Medicine, p. 1729-1742, 2013
-
Part of American Journal of Human Genetics, p. 167-172, 2013
-
High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
Part of Oncology Reports, p. 720-724, 2013
-
Part of Haematologica, 2012
-
Part of Journal of Experimental Medicine, p. 291-305, 2012
-
Molecular Studies of Mechanisms of Drug Resistance in Malignant Cells With Focus on Lymphomas
Part of European Journal of Cancer, 2012
-
Part of Leukemia Research, p. 438-443, 2011
-
Is a TNF Alpha Polymorphism Responsible for Mutations in the TP53 Gene?
Part of Scandinavian Journal of Immunology, p. 154-155, 2011
-
Part of The Pharmacogenomics Journal, p. 61-71, 2011
-
Part of Blood, p. 4489-4489, 2011
-
Part of American Journal of Hematology, p. 418-425, 2010
-
Part of Leukemia and Lymphoma, p. 1563-1566, 2010
-
Part of Leukemia Research, p. 60-66, 2009
-
Part of Leukemia and Lymphoma, p. 1723-1725, 2009
-
Part of American Journal of Hematology, p. 803-808, 2009
-
Folate-metabolizing genes in lymphoma patients from Sweden
Part of Scandinavian Journal of Immunology, p. 408-410, 2009
-
Part of British Journal of Haematology, p. 683-684, 2009
-
Part of British Journal of Haematology, p. 423-32, 2008
-
Part of Leukemia and Lymphoma, p. 477-487, 2008
-
Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas
Part of European Journal of Haematology, p. 283-289, 2007
-
Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma
Part of British Journal of Haematology, p. 68-71, 2007
-
Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma
Part of Leukemia and Lymphoma, p. 1038-1041, 2007
-
Part of Blood, p. 4930-4935, 2007
-
Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma
Part of Modern Pathology, p. 63-75, 2007
-
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
Part of Leukemia and Lymphoma, p. 1774-1779, 2007
-
Part of Leukemia and Lymphoma, p. 2221-2232, 2007
-
Part of Int J Cancer, p. 555-63, 2006
-
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Part of Mod Pathol, p. 1113-20, 2005
-
Part of Blood, p. 4894-5; author reply 4895, 2005
-
Part of Leukemia and Lymphoma, p. 2179-2189, 2002
Articles, review/survey
-
Part of International Journal of Hematologic Oncology, p. 391-396, 2013